Adaptive Biotechnologies Corp
NASDAQ:ADPT

Watchlist Manager
Adaptive Biotechnologies Corp Logo
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Watchlist
Price: 6.39 USD 6.15%
Market Cap: 943m USD
Have any thoughts about
Adaptive Biotechnologies Corp?
Write Note

Adaptive Biotechnologies Corp
Investor Relations

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. The company is headquartered in Seattle, Washington and currently employs 858 full-time employees. The company went IPO on 2019-06-27. The firm is focused on using the biology of the adaptive immune system to develop the diagnosis and treatment of disease. Its immune medicine platform combines a suite of chemistry, biology and machine learning to generate clinical immunomics data to decode the adaptive immune system. Its commercial research products include immunoSEQ and immunoSEQ T-MAP. immunoSEQ utilizes bias-controlled polymerase chain reaction (PCR) to sequence immune receptors from deoxyribonucleic (DNA). Its clonoSEQ diagnostic test detects and monitors the number of cancer cells that are present in a patient’s body during and after treatment, known as minimal residual disease (MRD). The company uses its T cell receptor (TCR)-Antigen Map to develop research solutions and diagnostic products, such as immunoSEQ T-MAP and T-Detect. The company also focuses on developing immune-mediated therapies in oncology and other disease areas.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Chad M. Robins M.B.A.
Co-Founder, CEO & Chairman
No Bio Available
Ms. Julie Rubinstein
President & COO
No Bio Available
Dr. Harlan S. Robins Ph.D.
Co-Founder & Chief Scientific Officer
No Bio Available
Dr. Sharon Benzeno Ph.D.
Chief Commercial Officer of Immune Medicine
No Bio Available
Mr. Christopher Carlson Ph.D.
Founder
No Bio Available
Mr. Kyle Piskel
VP, CFO & Principal Accounting Officer
No Bio Available
Ms. Karina Calzadilla
Vice President of Investor Relations
No Bio Available
Mr. Francis T. Lo
Chief People Officer
No Bio Available
Ms. Susan Bobulsky
Chief Commercial Officer of MRD
No Bio Available
Ms. Mary Pat Lancelotta
Senior Vice President of MRD BioPharma
No Bio Available

Contacts

Address
WASHINGTON
Seattle
1165 Eastlake Ave E
Contacts